SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 206.54+3.2%Jan 9 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: A.B. who wrote (3711)6/23/1997 3:06:00 PM
From: Cheryl Galt   of 32384
 
RE: SUGN's diabetes drugs, and their progress so far...

<They are still in the early stages, IND is planned for end of 97. >

SUGN's work sounds hopeful, and a 1997 IND would not be "early stage,"
so I checked the article at the link
biz.yahoo.com .
The studies are indeed in very early stages, and the IND is nowhere in sight.
Good news for Ligand investors; bad news for people with diabetes and their families.

The release says that, from its in vitro and animal studies, "SUGEN has identified several different drug candidates .... These compounds are now in preclinical development and the Company plans to select an initial IND candidate by the end of 1997.''

Regards, Cheryl
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext